About Akums
Akums is a company based in Delhi (India) founded in 2004.. Akums has raised $70 million across 1 funding round from investors including Quadria Capital. The company has 17,860 employees as of March 31, 2024. Akums has completed 2 acquisitions, including Ankur Drugs and Parabolic Drugs. Akums operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others.
- Headquarter Delhi, India
- Employees 17860 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Akums Drugs And Pharmaceuticals Limited
-
Annual Revenue
$481.07 M (USD)-1.44as on Mar 31, 2024
-
Net Profit
$39.49 M (USD)8476.7as on Mar 31, 2024
-
EBITDA
$54.09 M (USD)-4.46as on Mar 31, 2024
-
Total Equity Funding
$70 M (USD)
in 1 rounds
-
Latest Funding Round
$70 M (USD), Private Equity Round
Nov 13, 2019
- Investors
-
Employee Count
17860
as on Mar 31, 2024
-
Investments & Acquisitions
Ankur Drugs
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Akums
Akums is a publicly listed company on the NSE with ticker symbol AKUMS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Akums
Akums has successfully raised a total of $70M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $70 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $70.0M
-
First Round
First Round
(13 Nov 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Private Equity Round - Akums | Valuation | Quadria Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Akums
Akums has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Quadria Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Akums
Akums has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Ankur Drugs and Parabolic Drugs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CMO specializing in cephalosporins and beta-lactams
|
1997 | ||||
|
APIs, intermediates, and formulations are manufactured and exported.
|
1996 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Akums
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Akums Comparisons
Competitors of Akums
Akums operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Akums
Frequently Asked Questions about Akums
When was Akums founded?
Akums was founded in 2004 and raised its 1st funding round 15 years after it was founded.
Where is Akums located?
Akums is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Is Akums a funded company?
Akums is a funded company, having raised a total of $70M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $70M, raised on Nov 13, 2019.
How many employees does Akums have?
As of Mar 31, 2024, the latest employee count at Akums is 17,860.
What is the annual revenue of Akums?
Annual revenue of Akums is $481.07M as on Mar 31, 2024.
What does Akums do?
Akums was founded in 2004 and is headquartered in Delhi, India. As a contract development and manufacturing organization in the pharmaceutical sector, formulations are produced and exported across multiple dosage forms, including oral solids, liquids, sterile injectables, hormonals, ointments, cosmetics, Ayurvedics, and nutraceuticals. Therapeutic areas addressed encompass respiratory, neurology, analgesics, cardiovascular, immunomodulators, and supportive care.
Who are the top competitors of Akums?
Akums's top competitors include Jubilant Life Sciences, Nectar Lifesciences and Windlas.
Is Akums publicly traded?
Yes, Akums is publicly traded on NSE under the ticker symbol AKUMS.
How many acquisitions has Akums made?
Akums has made 2 acquisitions, including Ankur Drugs, and Parabolic Drugs.
Who are Akums's investors?
Akums has 1 investor. Key investors include Quadria Capital.
What is Akums's ticker symbol?
The ticker symbol of Akums is AKUMS on NSE.
What is Akums's valuation?
The valuation of Akums is $459.31M as of Nov 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.